Atracurium: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Atracurium. Educational only — not medical advice.
Labeled uses
Atracurium Besylate Injection, USP is indicated, as an adjunct to general anesthesia, to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
Source: FDA labeling via NIH DailyMed (set f7b6a720…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.